FDA Approves Pill That Cuts COVID Risk 67%

Getting exposed to COVID no longer means waiting anxiously to see if you'll get sick. The FDA just approved Xocova, the first pill proven to prevent infection after you've been around someone with the virus.

The medication, called ensitrelvir, works by stopping the virus from copying itself in your body. Take three pills right after exposure, then one pill daily for four more days, and your chances of getting sick drop by 67%.

Japanese pharmaceutical company Shionogi developed the drug, which has been used in Japan since 2024. Now it's heading to pharmacies across the US for anyone 12 and older.

The approval came after a massive trial involving over 2,000 people. Half took Xocova within 72 hours of household exposure to COVID, while the other half got a placebo. The difference was striking: the medication group had two-thirds fewer infections through day 10.

Side effects were minimal and matched the placebo group at about 15%. The most common issues were headaches, diarrhea, and cough. Serious problems were extremely rare at just 0.2%, and nobody needed hospitalization.

The Ripple Effect

This breakthrough changes how we can respond to COVID exposure in real time. Families don't have to isolate from sick loved ones and just hope for the best. Nursing homes can act quickly during outbreaks to protect vulnerable residents.

Dr. Frederick Hayden from the University of Virginia explains the medication could help anyone who doesn't want to catch COVID, whether at home, in healthcare facilities, or after travel exposures. It works regardless of vaccination status or whether you've had COVID before.

Unlike existing antivirals that treat people already infected, Xocova is the first to actually prevent symptomatic illness. That means fewer people getting sick, missing work, or developing long COVID complications.

The timing matters too. COVID continues affecting millions of lives, and even mild cases can trigger lasting health problems or worsen existing conditions. Having a prevention tool gives people real control after unexpected exposures.

Protection is finally available before symptoms start, not just after.